finance

Net debt stood at Rs 10,151 million and net debt to EBITDA at 0.91x Granules India has announced its financial results for the quarter ended December 31, 2025. Revenue from Operations of Q3FY26 stood at Rs 13,879 million, a growth of 22 per cent YoY driven by Finished Dosages (FD) segment in North America and […]

Impacted by delayed semaglutide approvals in Canada OneSource has posted the Q3FY26 results. Revenues were at Rs 2,903 million, down 26 per cent YoY, impacted by delayed semaglutide approvals in Canada. The EBITDA was at Rs 173 million, down 88 per cent YoY, due to lower revenue in the quarter and largely fixed cost base. […]

Reported revenue dips to Rs 932 crore in the same quarter Syngene International announced financial results for the third quarter of FY26. Peter Bains, Managing Director and CEO, Syngene International, said, “Our Q3 performance reflects the ongoing impact related to a single product from one of our large-molecule biologics clients. Outside of this factor, the […]

Sigachi’s entry into CF APIs positions the company in a structurally strong and innovation-led therapeutic segment with long-term demand visibility Sigachi Industries announced a significant milestone in its research and development pipeline with the successful advancement of a new Cystic Fibrosis (CF) Active Pharmaceutical Ingredients (APIs) combination comprising Vanzacaftor, Tezacaftor, and Deutivacaftor. The development marks […]

Registers PAT of Rs 12,098 Mn in the same quarter Dr Reddy’s Laboratories announced its consolidated financial results for the quarter and nine months ended December 31, 2025. The information mentioned in this release is based on consolidated financial statements under International Financial Reporting Standards (IFRS). Co-Chairman and MD, GV Prasad said: “Our growth in Q3FY26 […]

Care.fi aims to to scale to 300 Hospital units and 1 lakh monthly discharges to save 10 lakh+ admin hours and deliver a unified, patient-first experience from pre-auth to settlement Care.fi, a healthcare-focussed fintech founded by Vikrant Agrawal and Sidak Singh, announced its acquisition of Aldun, a discharge-automation platform known for enabling near-instant, 10-minute patient […]

Operating EBITDA increased by 13 per cent to Rs 305 crores JB Pharma posted Q3 FY26 results. The company registered revenue of Rs 1065 crores in Q3 FY26 (YoY growth of 11 per cent) and Rs 3244 crores in 9M FY26 (YoY growth of 9 per cent). Domestic formulations business recorded revenue of Rs 620 […]

Total issue size – Up To 40,99,200 equity shares of Rs 10 each Modern Diagnostic & Research Centre proposes to open its Initial Public Offering on December 31, 2025, aiming to raise Rs 36.89 crore (At Upper Price Band) by fresh issue of 40,99,200 equity shares, to be listed on the BSE SME platform. The […]

The fresh capital will be deployed towards scaling international operations, expanding the product portfolio and strengthening organisational capabilities PlasmaGen Biosciences, a leading biopharmaceutical company focussed on blood plasma-derived therapeutics, announced that it has raised Rs 150 crores in a minority equity financing round at an Rs 1500+ crore valuation. The round was led by ViNS […]

The company plans to utilise fund raised through net proceeds on prepayment and/or repayment, in full or in part, of all or a portion of certain outstanding borrowings availed by the Company and general corporate purposes Symbiotec Pharmalab, a research and development-driven, science-based pharmaceutical and biotechnology company with capabilities across three platforms- organic chemistry, biotechnology […]